Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Pathology

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2010.12.004PMID 21356345PMCID PMC3069822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy.

  2011cited by this paper
• PARP inhibitors: new tools to protect from inflammation.

  2010cited by this paper
• The Zn3 Domain of Human Poly(ADP-ribose) Polymerase-1 (PARP-1) Functions in Both DNA-dependent Poly(ADP-ribose) Synthesis Activity and Chromatin Compaction*

  2010cited by this paper
• Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation

  2010cited by this paper
• Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation

  2010cited by this paper
• Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation

  2010cited by this paper
• Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway--do androgens matter?

  2010cited by this paper
• Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress.

  2010cited by this paper
• Absence of Poly(ADP-Ribose) Polymerase 1 Delays the Onset of Salmonella enterica Serovar Typhimurium-Induced Gut Inflammation

  2010cited by this paper
• The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets.

  2010cited by this paper
• NAD+ Depletion Is Necessary and Sufficient forPoly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death

  2010cited by this paper
• Trypanosoma cruzi Induces the Reactive Oxygen Species-PARP-1-RelA Pathway for Up-regulation of Cytokine Expression in Cardiomyocytes*

  2010influential reference
• Poly(ADP-ribose) polymerase-1 modulates interferon-gamma-inducible protein (IP)-10 expression in murine embryonic fibroblasts by stabilizing IP-10 mRNA.

  2010cited by this paper
• Honokiol protects rats against eccentric exercise-induced skeletal muscle damage by inhibiting NF-kappaB induced oxidative stress and inflammation.

  2009influential reference
• Poly(ADP-Ribose) Polymerase-1 Regulates the Progression of Autoimmune Nephritis in Males by Inducing Necrotic Cell Death and Modulating Inflammation1

  2009cited by this paper
• Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites

  2009cited by this paper
• Poly(ADP-ribose) Polymerase 1 Interacts with Nuclear Respiratory Factor 1 (NRF-1) and Plays a Role in NRF-1 Transcriptional Regulation*

  2009cited by this paper
• Superoxide, NO, peroxynitrite and PARP in circulatory shock and inflammation.

  2009cited by this paper
• Inhibition of LPS-induced pulmonary inflammation by specific flavonoids.

  2009cited by this paper
• Identification of the ADP-ribosylation sites in the PARP-1 automodification domain: analysis and implications.

  2009influential reference
• Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes.

  2009cited by this paper
• PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

  2009cited by this paper
• Effects of PARP‐1 deficiency on airway inflammatory cell recruitment in response to LPS or TNF: differential effects on CXCR2 ligands and Duffy antigen receptor for chemokines

  2009cited by this paper
• The roles of poly(ADP-ribose)-metabolizing enzymes in alkylation-induced cell death

  2008cited by this paper
• Cardiomyocyte death and renewal in the normal and diseased heart.

  2008cited by this paper
• Poly(ADP-ribose) polymerase activity in different pathologies--the link to inflammation and infarction.

  2008cited by this paper
• A Third Zinc-binding Domain of Human Poly(ADP-ribose) Polymerase-1 Coordinates DNA-dependent Enzyme Activation*

  2008cited by this paper
• Glutathione content as a potential mediator of the vulnerability of cultured fetal cortical neurons to ethanol‐induced apoptosis

  2008cited by this paper
• Domain C of human poly(ADP-ribose) polymerase-1 is important for enzyme activity and contains a novel zinc-ribbon motif.

  2008cited by this paper
• Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP‐1‐dependent energy deprivation

  2008cited by this paper
• Role of free radicals and poly(ADP-ribose)polymerase-1 in the development of spinal cord injury: new potential therapeutic targets.

  2008cited by this paper
• Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

  2008cited by this paper
• Poly ADP-ribose polymerase-1: an international molecule of mystery.

  2008cited by this paper
• Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia.

  2008cited by this paper
• Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment

  2008cited by this paper
• Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury

  2008cited by this paper
• Poly(ADP-ribose) makes a date with death.

  2007cited by this paper
• Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.

  2007cited by this paper
• Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells.

  2007cited by this paper
• NAD+ metabolism in health and disease.

  2007cited by this paper
• The New Zealand Asthma and Allergy Cohort Study (NZA2CS): Assembly, Demographics and Investigations

  2007cited by this paper
• Abstract 1131: PARP1 is required for Adhesion Molecule Expression in Atherogenesis

  2007cited by this paper
• Poly(ADP-Ribose) Polymerase Inhibition Reduces Atherosclerotic Plaque Size and Promotes Factors of Plaque Stability in Apolipoprotein E–Deficient Mice: Effects on Macrophage Recruitment, Nuclear Factor-&kgr;B Nuclear Translocation, and Foam Cell Death

  2007cited by this paper
• The DNA Binding and Catalytic Domains of Poly(ADP-Ribose) Polymerase 1 Cooperate in the Regulation of Chromatin Structure and Transcription

  2007cited by this paper
• Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D.

  2007cited by this paper
• Distinct cardiodynamic and molecular characteristics during early and late stages of sepsis-induced myocardial dysfunction.

  2007cited by this paper
• Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and microangiopathy.

  2007cited by this paper
• Regulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1

  2007cited by this paper
• Ca2+‐dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP‐ribose) polymerase‐1 activation during glutamate excitotoxicity

  2007cited by this paper
• PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells

  2007cited by this paper
• Poly(ADP-ribose): novel functions for an old molecule

  2006cited by this paper
• Activation of the Poly(ADP-Ribose) Polymerase Pathway in Human Heart Failure

  2006cited by this paper
• Poly(ADP-ribose) Polymerase-1 Signaling to Mitochondria in Necrotic Cell Death Requires RIP1/TRAF2-mediated JNK1 Activation*

  2006cited by this paper
• Nitric oxide, cell bioenergetics and neurodegeneration

  2006cited by this paper
• Nitric Oxide-dependent Negative Feedback of PARP-1 trans-Activation of the Inducible Nitric-oxide Synthase Gene*

  2006cited by this paper
• Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death.

  2006cited by this paper
• Poly(ADP-ribose) Polymerase-1 Inhibition Prevents Eosinophil Recruitment by Modulating Th2 Cytokines in a Murine Model of Allergic Airway Inflammation: A Potential Specific Effect on IL-51

  2006cited by this paper
• Poly(ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation.

  2006cited by this paper
• Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death

  2006cited by this paper
• Differential regulation of CXC ligand 1 transcription in melanoma cell lines by poly(ADP-ribose) polymerase-1

  2006cited by this paper
• Poly(ADP-ribose) (PAR) polymer is a death signal

  2006cited by this paper
• Apoptosis-inducing factor: vital and lethal.

  2006cited by this paper
• Txk, a member of the non‐receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP‐ribose) polymerase 1 and elongation factor 1α and regulates interferon‐γ gene transcription in Th1 cells

  2006cited by this paper
• Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2.

  2006cited by this paper
• Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein.

  2006cited by this paper
• Poly(ADP-ribose) polymerase-1 mediated caspase-independent cell death after ischemia/reperfusion.

  2005cited by this paper
• Pivotal Role of Akt Activation in Mitochondrial Protection and Cell Survival by Poly(ADP-ribose)polymerase-1 Inhibition in Oxidative Stress*

  2005cited by this paper
• Specific binding of poly(ADP-ribose) polymerase-1 to cruciform hairpins.

  2005cited by this paper
• Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications.

  2005cited by this paper
• Inhibitors of Poly(ADP-Ribose) Polymerase Modulate Signal Transduction Pathways and Secondary Damage in Experimental Spinal Cord Trauma

  2005cited by this paper
• Regulation of Poly(ADP-ribose) Polymerase-1 by DNA Structure-specific Binding*

  2005cited by this paper
• Acetylation of Poly(ADP-ribose) Polymerase-1 by p300/CREB-binding Protein Regulates Coactivation of NF-κB-dependent Transcription*

  2005cited by this paper
• Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

  2005cited by this paper
• Nuclear Poly(ADP-ribose) Polymerase-1 Rapidly Triggers Mitochondrial Dysfunction*

  2005cited by this paper
• Mitochondrial impairment induced by poly(ADP‐ribose) polymerase‐1 activation in cortical neurons after oxygen and glucose deprivation

  2005cited by this paper
• IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

  2005cited by this paper
• In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs)

  2005cited by this paper
• NAD+ as a metabolic link between DNA damage and cell death

  2005cited by this paper
• DNA-induced dimerization of poly(ADP-ribose) polymerase-1 triggers its activation.

  2005cited by this paper
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

  2005cited by this paper
• Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice

  2005cited by this paper
• Angiotensin II-Mediated Endothelial Dysfunction: Role of Poly(ADP-ribose) Polymerase Activation

  2004cited by this paper
• Poly(ADP-ribose) Polymerase-1-mediated Cell Death in Astrocytes Requires NAD+ Depletion and Mitochondrial Permeability Transition*

  2004cited by this paper
• Interaction Between Inducible Nitric Oxide Synthase and Poly(ADP-ribose) Polymerase in Focal Ischemic Brain Injury

  2004cited by this paper
• NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1.

  2004cited by this paper
• Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1.

  2004cited by this paper
• Activator protein‐1 signalling pathway and apoptosis are modulated by poly(ADP‐ribose) polymerase‐1 in experimental colitis

  2004cited by this paper
• PARP goes transcription.

  2003cited by this paper
• Poly(ADP-Ribose) Polymerase-1 Regulates Activation of Activator Protein-1 in Murine Fibroblasts1

  2003cited by this paper
• Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma.

  2003cited by this paper
• Role of poly(adenosine diphosphate–ribose) polymerase 1 in septic peritonitis

  2003cited by this paper
• Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.

  2003cited by this paper
• Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock.

  2003cited by this paper
• Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor

  2002cited by this paper
• Poly(ADP-Ribose) Polymerase Is Activated in Subjects at Risk of Developing Type 2 Diabetes and Is Associated With Impaired Vascular Reactivity

  2002cited by this paper
• Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.

  2002cited by this paper
• Poly(ADP-ribose) Polymerase-2 (PARP-2) Is Required for Efficient Base Excision DNA Repair in Association with PARP-1 and XRCC1*

  2002cited by this paper
• Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.

  2002cited by this paper
• Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase

  2001cited by this paper
• Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.

  2001cited by this paper

• Synaptic potentiation requires PARP1 activation: prevailing concepts are revisited

  2026cites this paper
• Poly(ADP-ribose) polymerase (PARP) inhibitors in cardiovascular, and cerebrovascular diseases: mechanisms, current trends and challenge for clinical translation.

  2026cites this paper
• Effect of heme oxygenase-1 on the expression of interferon-stimulated genes

  2025cites this paper
• Biochemical Insights into the Effects of a Small Molecule Drug Candidate on Imatinib-Induced Cardiac Inflammation

  2025cites this paper
• Poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease

  2025cites this paper
• Role of Esketamine in Attenuating Neuroinflammation and Improving Postoperative Cognitive Function via Autophagy Activation Through PARP1 Targeting

  2025cites this paper
• Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats

  2025cites this paper
• Network pharmacology and molecular simulation insights into the anti-diabetic and anti-inflammatory mechanisms of Ricinus communis.

  2025cites this paper
• Molecular insights into PARP1 activation: structural dynamics of DNA, NAD+, and zinc‑mediated allosteric regulation.

  2025cites this paper
• Poly(ADP-ribose) polymerase-1 in breast cancers: expression level and its association in various molecular subtypes with a focus in Africa

  2025cites this paper
• Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition

  2025cites this paper
• PARP1-NFATc1-PD1 pathway of maturation and stability of CD8+T cells is beneficial against chronic Trypanosoma cruzi infection

  2025cites this paper
• PARP1 deficiency induces aging-associated cardiac failure via activation of Akt signalling

  2025cites this paper
• "Yin-Yang" of PARP1 in genotoxic and inflammatory response.

  2025cites this paper
• Cytotoxicity and molecular mechanisms of quercetin, gallic acid, and pinocembrin in Caco-2 cells: insights from cell viability assays, network pharmacology, and molecular docking

  2025cites this paper
• PARP-1 inhibition attenuates tumor pathology in a novel murine model of diabetes-associated colitis-induced colorectal cancer.

  2025cites this paper
• Minocycline Regulates PARP-1 and HDAC3 Pathways to Inhibit Inflammation and Oxidative Stress in LPS-Induced Acute Lung Injury

  2025cites this paper
• Harnessing Extracellular microRNAs for Diagnostics and Therapeutics in Acute Systemic Inflammation

  2024cites this paper
• The RNA Binding Protein Tristetraprolin Contributes to CFTR mRNA Stability in Cystic Fibrosis.

  2024cites this paper
• Colon-Targeted Poly(ADP-ribose) Polymerase Inhibitors Synergize Therapeutic Effects of Mesalazine Against Rat Colitis Induced by 2,4-Dinitrobenzenesulfonic Acid

  2024cites this paper
• Pancreatic β‑cell apoptosis in type 2 diabetes is related to post‑translational modifications of p53 (Review).

  2024cites this paper
• PAR level mediates the link between ROS and inflammatory response in patients with type 2 diabetes mellitus

  2024cites this paper
• Poly-(ADP-ribose) polymerase 1-modulated production of CXCL1 in the dorsal root ganglion and spinal dorsal horn exacerbated inflammatory pain in rats.

  2024cites this paper
• Chitosan/siRNA nanoparticles targeting PARP-1 attenuate Neuroinflammation and apoptosis in hyperglycemia-induced oxidative stress in Neuro2a cells.

  2024cites this paper
• Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight

  2024cites this paper
• Current state of knowledge of triclosan (TCS)-dependent reactive oxygen species (ROS) production.

  2024cites this paper
• Protective Effects of Baicalein on Lipopolysaccharide-Induced AR42J PACs through Attenuation of Both Inflammation and Pyroptosis via Downregulation of miR-224-5p/PARP1

  2024cites this paper
• NAD+ enhancers as therapeutic agents in the cardiorenal axis

  2024cites this paper
• Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide

  2023cites this paper
• Human umbilical cord mesenchymal stromal cell small extracellular vesicle transfer of microRNA-223-3p to lung epithelial cells attenuates inflammation in acute lung injury in mice

  2023cites this paper
• PARP1 inhibition protects mice against Japanese encephalitis virus infection.

  2023cites this paper
• Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats

  2023cites this paper
• The potential role of upregulated PARP-1/RIPK1 expressions in amikacin-induced oxidative damage and nephrotoxicity in Wistar rats.

  2023cites this paper
• Mycobacterium tuberculosis: Pathogenesis and therapeutic targets

  2023cites this paper
• Uro-protective role of chrysin against cyclophosphamide-induced hemorrhagic cystitis in rats involving the turning-off NF-κB/P38-MAPK, NO/PARP-1 and STAT-3 signaling cascades.

  2023cites this paper
• PARG suppresses tumorigenesis and downregulates genes controlling angiogenesis, inflammatory response, and immune cell recruitment

  2022cites this paper
• Poly-ADP-ribose polymerase (PARP) inhibitors and ovarian function.

  2022cites this paper
• Harnessing NAD+ Metabolism as Therapy for Cardiometabolic Diseases

  2022cites this paper
• Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine

  2022cites this paper
• Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke

  2022cites this paper
• The Role of PARP‐1 and NF‐κB in Bile‐Induced DNA Damage and Oncogenic Profile in Hypopharyngeal Cells

  2022cites this paper
• The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis

  2022influential citation
• Development and bioevaluation of controlled release 5-aminoisoquinoline nanocomposite: a synergistic anticancer activity against human colon cancer

  2022cites this paper
• Role of poly(ADP-ribose) polymerase-1 in regulating human islet cell differentiation

  2022cites this paper
• Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson’s Disease

  2022cites this paper
• Regulation of radiation‐induced liver damage by modulation of SIRT‐1 activity: In vivo rat model

  2022cites this paper
• Mineral deposition intervention through reduction of phosphorus intake suppresses osteoarthritic lesions in temporomandibular joint.

  2021cites this paper
• Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice

  2021cites this paper
• PARkinson's: From cellular mechanisms to potential therapeutics.

  2021cites this paper
• Host regulator PARP1 contributes to sex differences and immune responses in a mouse model of tuberculosis

  2021influential citation
• Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report

  2021cites this paper
• Effects of Poly (ADP-ribose) Polymerase Inhibition on DNA Integrity and Gene Expression in Ovarian Follicular Cells in Mice with Endotoxemia

  2021cites this paper
• Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis

  2021cites this paper
• Carbamazepine-induced renal toxicity may be associated with oxidative stress and apoptosis in male rat

  2021cites this paper
• The Oxidative Stress and Chronic Inflammatory Process in Chagas Disease: Role of Exosomes and Contributing Genetic Factors

  2021cites this paper
• PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.

  2021cites this paper
• Magnetic Thermoresponsive Nanocomposite for Targeted PARP-1 in Colorectal Adenocarcinoma, an Approach for Tumor Dual Therapy

  2021cites this paper
• Pannexin-1 Contributes to the Apoptosis of Spinal Neurocytes in Spinal Cord Injury

  2021cites this paper
• Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease

  2021cites this paper
• Hesperetin may alleviate the development of doxorubicin-induced pulmonary toxicity by decreasing oxidative stress and apoptosis in male rats.

  2021cites this paper
• Application of Laser Microirradiation in the Investigations of Cellular Responses to DNA Damage

  2021cites this paper
• Stroke promotes the development of brain atrophy and delayed cell death in hypertensive rats

  2020cites this paper
• Teucrium Species: Biology and Applications

  2020cites this paper
• The role of selenium in cell survival and its correlation with protective effects against cardiovascular disease: A literature review.

  2020cites this paper
• The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells

  2020cites this paper
• Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease

  2020cites this paper
• Association of NAD + ADP-ribosyltransferase 1 gene polymorphism with the development of neonatal diabetes mellitus

  2020cites this paper
• Novel Long Noncoding RNA, Macrophage Inflammation-Suppressing Transcript (MIST), Regulates Macrophage Activation During Obesity

  2020cites this paper
• PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease

  2020cites this paper
• Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice

  2020cites this paper
• Effects of The Poly(ADP-ribose) Polymerase Inhibitor Olaparib in Cerulein-Induced Pancreatitis.

  2020cites this paper
• Comparison of clinical effectiveness of nurse led care among Chinese patients with cancer: A prospective study evaluating effective patient care compared to consultant oncologist.

  2020cites this paper
• Anticancer Activity of Secondary Metabolites of Teucrium Species

  2020cites this paper
• Assessment of PARP-1 Distribution in Tissues of Cynomolgus Monkeys

  2020cites this paper
• Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway

  2020cites this paper
• NAD+ in sulfur mustard toxicity.

  2020cites this paper
• Dietary CCPS from bitter gourd attenuates sodium arsenite induced female reproductive ailments cum infertility in wistar rats: anti-inflammatory and anti-apoptotic role.

  2019cites this paper
• Co-treatment With BGP-15 Exacerbates 5-Fluorouracil-Induced Gastrointestinal Dysfunction

  2019cites this paper
• Novel insights into PARPs in gene expression: regulation of RNA metabolism

  2019cites this paper
• Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization

  2019cites this paper
• PARP-1 mediated cell death is directly activated by ZIKV infection.

  2019cites this paper
• Protective effects of quercetin-3-O-α-l-arabinopyranoside against UVA induced apoptosis via regulating inflammatory pathways in ARPE-19 cells and Balb/c mice

  2019cites this paper
• c-Abl–Mediated Tyrosine Phosphorylation of PARP1 Is Crucial for Expression of Proinflammatory Genes

  2019cites this paper
• Le suppresseur de tumeurs PALB2 : étude fonctionnelle du domaine N-terminal de liaison à l'ADN et établissement de modèles de létalité synthétique

  2019cites this paper
• ARTD1 in Myeloid Cells Controls the IL-12/18–IFN-γ Axis in a Model of Sterile Sepsis, Chronic Bacterial Infection, and Cancer

  2019cites this paper
• PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.

  2019cites this paper
• PARP inhibitors in ovarian cancer.

  2019cites this paper
• Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate.

  2019cites this paper
• Poly(ADP-ribosylated) proteins in β-amyloid peptide-stimulated microglial cells.

  2019cites this paper
• Inflammation, necrosis, and the kinase RIP3 are key mediators of AAG-dependent alkylation-induced retinal degeneration

  2019cites this paper
• Contribution of poly(ADP‐ribose)polymerase‐1 activation and apoptosis in trichloroethene‐mediated autoimmunity

  2019cites this paper
• Inflammation-induced DNA damage, mutations and cancer.

  2019cites this paper
• Insight into the binding of a synthetic nitro-flavone derivative with human poly-ADP ribose polymerase 1.

  2019cites this paper
• PARP-14 Promotes Survival of Mammalian α but Not β Pancreatic Cells Following Cytokine Treatment

  2019cites this paper
• The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond

  2019cites this paper
• Crellastatin A, a PARP‐1 Inhibitor Discovered by Complementary Proteomic Approaches

  2019cites this paper
• Rôle des miARN et des ARE-BP dans la mucoviscidose

  2018cites this paper
• The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third‐degree burn injury

  2018cites this paper
• Involvement of poly(ADP-ribose) polymerase-1 in Chinese patients with glioma: a potential target for effective patient care

  2018cites this paper
• Anti-apoptotic effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, against multiple organ damage induced by gamma irradiation in rats

  2018cites this paper